P-ISSN 2587-2400 | E-ISSN 2587-196X

Ejmo Kapak

EJMO Volume : 7 Issue : 1 Year : 2023

COVID-19 in EJMO 7/1EJMO Current Issue EJMO Archive EJMO & Congress Most Cited Articles Ahead of Print Most Accessed Articles

Copyright Transfer Form

ICMJE COI Form

EJMO Sponsors

Glead
Pfizer
Roche
Amgen
Astellas
Bristol-Myers Squibb
Arven
Johnson Johnson
Merck
Novartis
Omnigen
Mustafa Nevzat
TEVA
Trpharm

In-vitro Evaluation of Effects of Mesenchymal Stem Cells on TLR3, TLR7/8 and TLR9-activated Natural Killer Cells

Copyright � 2023 Eurasian Journal of Medicine and Oncology, EJMO

EJMO & EJMO